Biblio
2023
Hong JHan, Yong CHan, Heng HLee, Chan JYongsheng, Lau MChan, Chen J, Lee JYi, Lim AHerbert, Li Z, Guan P, et al. Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies. Gut. 2023.
2020
Tan GFangmin, Goh S, Lim AHerbert, Liu W, Lee JYi, Rajasegaran V, Xiu SXin, Tay TKwang Yong, Selvarajan S, Ng CChuan-Youn, et al. Bizarre giant cells in human angiosarcoma exhibit chemoresistance and confer poor survival outcomes. Cancer Sci. 2020.